List of Tables

Table 1. Inactivated Influenza Vaccine Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Inactivated Influenza Vaccine Market Restraints

Table 3. Inactivated Influenza Vaccine Market Trends

Table 4. Inactivated Influenza Vaccine Industry Policy

Table 5. Global Inactivated Influenza Vaccine Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Inactivated Influenza Vaccine Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Inactivated Influenza Vaccine Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Inactivated Influenza Vaccine Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Inactivated Influenza Vaccine Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Inactivated Influenza Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Inactivated Influenza Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global Inactivated Influenza Vaccine Manufacturers Product Type

Table 13. Head Office and Inactivated Influenza Vaccine Production Site of Key Manufacturer

Table 14. Inactivated Influenza Vaccine Capacity of Major Manufacturers and Future Plan

Table 15. China Inactivated Influenza Vaccine Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Inactivated Influenza Vaccine Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Inactivated Influenza Vaccine Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Inactivated Influenza Vaccine Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Inactivated Influenza Vaccine Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Inactivated Influenza Vaccine Production by Region, 2020-2025, (K Units)

Table 21. Global Inactivated Influenza Vaccine Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Inactivated Influenza Vaccine Upstream (Raw Materials)

Table 23. Global Inactivated Influenza Vaccine Typical Customers

Table 24. Inactivated Influenza Vaccine Typical Distributors

Table 25. by Type, Global Inactivated Influenza Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Inactivated Influenza Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Inactivated Influenza Vaccine Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Inactivated Influenza Vaccine Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Inactivated Influenza Vaccine Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Inactivated Influenza Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Inactivated Influenza Vaccine Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Inactivated Influenza Vaccine Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Inactivated Influenza Vaccine Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Inactivated Influenza Vaccine Sales Quantity Market Share, 2020-2031

Table 35. CSL Limited Company Information, Head Office, Market Area, and Industry Position

Table 36. CSL Limited Inactivated Influenza Vaccine Models, Specifications, and Application

Table 37. CSL Limited Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. CSL Limited Company Profile and Main Business

Table 39. CSL Limited Recent Developments

Table 40. GSK Company Information, Head Office, Market Area, and Industry Position

Table 41. GSK Inactivated Influenza Vaccine Models, Specifications, and Application

Table 42. GSK Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. GSK Company Profile and Main Business

Table 44. GSK Recent Developments

Table 45. Sanofi Pasteur Company Information, Head Office, Market Area, and Industry Position

Table 46. Sanofi Pasteur Inactivated Influenza Vaccine Models, Specifications, and Application

Table 47. Sanofi Pasteur Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Sanofi Pasteur Company Profile and Main Business

Table 49. Sanofi Pasteur Recent Developments

Table 50. Viatris Company Information, Head Office, Market Area, and Industry Position

Table 51. Viatris Inactivated Influenza Vaccine Models, Specifications, and Application

Table 52. Viatris Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Viatris Company Profile and Main Business

Table 54. Viatris Recent Developments

Table 55. Hualan Biological Company Information, Head Office, Market Area, and Industry Position

Table 56. Hualan Biological Inactivated Influenza Vaccine Models, Specifications, and Application

Table 57. Hualan Biological Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Hualan Biological Company Profile and Main Business

Table 59. Hualan Biological Recent Developments

Table 60. AstraZeneca Company Information, Head Office, Market Area, and Industry Position

Table 61. AstraZeneca Inactivated Influenza Vaccine Models, Specifications, and Application

Table 62. AstraZeneca Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. AstraZeneca Company Profile and Main Business

Table 64. AstraZeneca Recent Developments

Table 65. Sinovac Biotech Company Information, Head Office, Market Area, and Industry Position

Table 66. Sinovac Biotech Inactivated Influenza Vaccine Models, Specifications, and Application

Table 67. Sinovac Biotech Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. Sinovac Biotech Company Profile and Main Business

Table 69. Sinovac Biotech Recent Developments

Table 70. Aleph Biomedical Company Information, Head Office, Market Area, and Industry Position

Table 71. Aleph Biomedical Inactivated Influenza Vaccine Models, Specifications, and Application

Table 72. Aleph Biomedical Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. Aleph Biomedical Company Profile and Main Business

Table 74. Aleph Biomedical Recent Developments

Table 75. Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position

Table 76. Abbott Laboratories Inactivated Influenza Vaccine Models, Specifications, and Application

Table 77. Abbott Laboratories Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. Abbott Laboratories Company Profile and Main Business

Table 79. Abbott Laboratories Recent Developments

Table 80. Novartis International Company Information, Head Office, Market Area, and Industry Position

Table 81. Novartis International Inactivated Influenza Vaccine Models, Specifications, and Application

Table 82. Novartis International Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 83. Novartis International Company Profile and Main Business

Table 84. Novartis International Recent Developments

Table 85. Changchun Institute of Biological Company Information, Head Office, Market Area, and Industry Position

Table 86. Changchun Institute of Biological Inactivated Influenza Vaccine Models, Specifications, and Application

Table 87. Changchun Institute of Biological Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 88. Changchun Institute of Biological Company Profile and Main Business

Table 89. Changchun Institute of Biological Recent Developments

Table 90. BCHT Company Information, Head Office, Market Area, and Industry Position

Table 91. BCHT Inactivated Influenza Vaccine Models, Specifications, and Application

Table 92. BCHT Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 93. BCHT Company Profile and Main Business

Table 94. BCHT Recent Developments

Table 95. Jiangsu GDK Company Information, Head Office, Market Area, and Industry Position

Table 96. Jiangsu GDK Inactivated Influenza Vaccine Models, Specifications, and Application

Table 97. Jiangsu GDK Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 98. Jiangsu GDK Company Profile and Main Business

Table 99. Jiangsu GDK Recent Developments

Table 100. KM Biologics Company Information, Head Office, Market Area, and Industry Position

Table 101. KM Biologics Inactivated Influenza Vaccine Models, Specifications, and Application

Table 102. KM Biologics Inactivated Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 103. KM Biologics Company Profile and Main Business

Table 104. KM Biologics Recent Developments

List of Figures

Figure 1. Inactivated Influenza Vaccine Picture

Figure 2. Global Inactivated Influenza Vaccine Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Inactivated Influenza Vaccine Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Inactivated Influenza Vaccine Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Inactivated Influenza Vaccine Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Inactivated Influenza Vaccine Sales Quantity (K Units) & (2020-2031)

Figure 7. China Inactivated Influenza Vaccine Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Inactivated Influenza Vaccine Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Inactivated Influenza Vaccine Market Share of Global, 2020-2031

Figure 10. Global Inactivated Influenza Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Inactivated Influenza Vaccine Key Participants, Market Share, 2024

Figure 12. Global Inactivated Influenza Vaccine Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Inactivated Influenza Vaccine Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Inactivated Influenza Vaccine Production Market Share & Forecast by Region, 2020-2031

Figure 15. Inactivated Influenza Vaccine Industry Chain

Figure 16. Inactivated Influenza Vaccine Procurement Model

Figure 17. Inactivated Influenza Vaccine Sales Model

Figure 18. Inactivated Influenza Vaccine Sales Channels, Direct Sales, and Distribution

Figure 19. Trivalent Influenza Vaccine

Figure 20. Quadrivalent Influenza Vaccine

Figure 21. by Type, Global Inactivated Influenza Vaccine Consumption Value, 2020-2031, US$ Million

Figure 22. by Type, Global Inactivated Influenza Vaccine Consumption Value Market Share, 2020-2031

Figure 23. by Type, Global Inactivated Influenza Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 24. by Type, Global Inactivated Influenza Vaccine Sales Quantity Market Share, 2020-2031

Figure 25. by Type, Global Inactivated Influenza Vaccine Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 26. Children

Figure 27. Adolescence

Figure 28. Adults

Figure 29. Elderly

Figure 30. by Application, Global Inactivated Influenza Vaccine Consumption Value, 2020-2031, US$ Million

Figure 31. by Application, Global Inactivated Influenza Vaccine Revenue Market Share, 2020-2031

Figure 32. by Application, Global Inactivated Influenza Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 33. by Application, Global Inactivated Influenza Vaccine Sales Quantity Market Share, 2020-2031

Figure 34. by Application, Global Inactivated Influenza Vaccine Price, 2020-2031, (US$/Unit)

Figure 35. By Region, Global Inactivated Influenza Vaccine Consumption Value Market Share, 2020-2031

Figure 36. By Region, Global Inactivated Influenza Vaccine Sales Quantity Market Share, 2020-2031

Figure 37. North America Inactivated Influenza Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 38. By Country, North America Inactivated Influenza Vaccine Consumption Value Market Share, 2024

Figure 39. Europe Inactivated Influenza Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 40. By Country, Europe Inactivated Influenza Vaccine Consumption Value Market Share, 2024

Figure 41. Asia Pacific Inactivated Influenza Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 42. By Country/Region, Asia Pacific Inactivated Influenza Vaccine Consumption Value Market Share, 2024

Figure 43. South America Inactivated Influenza Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 44. By Country, South America Inactivated Influenza Vaccine Consumption Value Market Share, 2024

Figure 45. Middle East & Africa Inactivated Influenza Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 46. United States Inactivated Influenza Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 47. by Type, United States Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 48. by Application, United States Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 49. Europe Inactivated Influenza Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 50. by Type, Europe Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 51. by Application, Europe Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 52. China Inactivated Influenza Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 53. by Type, China Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 54. by Application, China Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 55. Japan Inactivated Influenza Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 56. by Type, Japan Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 57. by Application, Japan Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 58. South Korea Inactivated Influenza Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 59. by Type, South Korea Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 60. by Application, South Korea Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 61. Southeast Asia Inactivated Influenza Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 62. by Type, Southeast Asia Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 63. by Application, Southeast Asia Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 64. India Inactivated Influenza Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 65. by Type, India Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 66. by Application, India Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 67. Middle East & Africa Inactivated Influenza Vaccine Sales Quantity, 2020-2031, (K Units)

Figure 68. by Type, Middle East & Africa Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 69. by Application, Middle East & Africa Inactivated Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up Approaches

Figure 73. Top-down Approaches